 | The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data - Yahoo Finance
finance.yahoo.com - April 8 at 3:39 PM |
 | IMARA Inc. (NASDAQ:IMRA) Short Interest Update
americanbankingnews.com - April 1 at 12:00 PM |
 | The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO - Benzinga
benzinga.com - March 31 at 9:45 AM |
| The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings - Benzinga
benzinga.com - March 30 at 8:41 AM |
 | Chicago: AHF Health Center-Lakeview to Open March 31st - StreetInsider.com
streetinsider.com - March 29 at 12:38 PM |
 | Imara Opens Applications for the Second-Annual 'Real Impact' Community Support Program to Address Unmet Needs Affecting People with Rare Genetic Blood Disorders - GlobeNewswire
globenewswire.com - March 29 at 12:38 PM |
| Imara Opens Applications for the Second-Annual ‘Real Impact’ Community Support Program to Address Unmet Needs Affecting People with Rare Genetic Blood Disorders
finance.yahoo.com - March 29 at 7:37 AM |
| SHAREHOLDER ALERT: Investigation of IMARA Inc. Announced by Holzer & Holzer, LLC - Yahoo Finance
finance.yahoo.com - March 22 at 7:21 PM |
|
| SHAREHOLDER ALERT: Investigation of IMARA Inc. Announced by Holzer & Holzer, LLC
finance.yahoo.com - March 22 at 7:20 PM |
 | Imara gets positive DMC opinion for higher dose arm in mid-stage sickle cell disease trial - Seeking Alpha
seekingalpha.com - March 17 at 12:18 PM |
| Imara Inc. (IMRA) Begins Higher Dose Arms in Global Phase 2b Clinical Trials of IMR-687 for Sickle Cell Disease and Beta-Thalassemia - StreetInsider.com
streetinsider.com - March 17 at 7:17 AM |
| Imara Announces Opening of Higher Dose Arms in Global Phase 2b Clinical Trials of IMR-687 for Sickle Cell Disease and Beta-Thalassemia - GlobeNewswire
globenewswire.com - March 17 at 7:17 AM |
| Imara Announces Opening of Higher Dose Arms in Global Phase 2b Clinical Trials of IMR-687 for Sickle Cell Disease and Beta-Thalassemia
finance.yahoo.com - March 17 at 7:17 AM |
 | IMARA, Inc. Rings the Nasdaq Stock Market Closing Bell
nasdaq.com - March 16 at 10:39 AM |
| Bronstein, Gewirtz & Grossman, LLC Announces Investigation of IMARA, Inc. (IMRA) and Encourages Investors to Contact the Firm - Yahoo Finance
finance.yahoo.com - March 15 at 11:37 PM |
| Bronstein, Gewirtz & Grossman, LLC Announces Investigation of IMARA, Inc. (IMRA) and Encourages Investors to Contact the Firm
finance.yahoo.com - March 15 at 1:36 PM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of IMARA, Inc. - IMRA - Yahoo Finance
finance.yahoo.com - March 15 at 12:07 AM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of IMARA, Inc. - IMRA
finance.yahoo.com - March 10 at 7:15 AM |
| Puerto Rico: New AHF Carolina Healthcare Center and AHF Pharmacy to Open March 9 - Paseo del Prado Shopping Center - StreetInsider.com
streetinsider.com - March 9 at 10:33 AM |
| Earnings Scheduled For March 5, 2021 - Yahoo Finance
finance.yahoo.com - March 5 at 8:42 PM |
| Form 8-K IMARA Inc. For: Mar 05 - StreetInsider.com
streetinsider.com - March 5 at 8:42 PM |
| Imara, Inc. (IMRA) CEO Rahul Ballal on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 5 at 8:42 PM |
| Second Sight Medical Products, XTL Biopharmaceuticals leads healthcare gainers - Seeking Alpha
seekingalpha.com - March 5 at 3:08 PM |
| Mid-Afternoon Market Update: Nasdaq Surges 150 Points; Calyxt Shares Slide - Benzinga
benzinga.com - March 5 at 3:08 PM |
|
| Form 10-K IMARA Inc. For: Dec 31 - StreetInsider.com
streetinsider.com - March 5 at 9:27 AM |
| Imara Inc to Host Earnings Call - Yahoo Finance
finance.yahoo.com - March 5 at 9:27 AM |
| Imara Reports Full Year 2020 Financial Results and Business Highlights - GlobeNewswire
globenewswire.com - March 5 at 9:27 AM |
| Imara to Webcast Conference Call of Full Year 2020 Financial Results and Business Highlights - GlobeNewswire
globenewswire.com - February 27 at 1:34 AM |
| Imara to Webcast Conference Call of Full Year 2020 Financial Results and Business Highlights
finance.yahoo.com - February 27 at 1:34 AM |
| Alpha Phi Alpha Fraternity, Inc.'s Project Alpha and Global AIDS Service Organization Extend Partnership to Address Rising STIs Among Black Youth - StreetInsider.com
streetinsider.com - February 26 at 8:33 PM |
| 'Out of the Closet' Thrift Store Opens in Orlando to Address Orlando's HIV/AIDS Epidemic - StreetInsider.com
streetinsider.com - February 26 at 8:33 PM |
| Community Leaders Join Forces with Historic African American Cultural Institution to Culminate Black History Month by Providing Critical Needs to Food Insecure Individuals and Families - StreetInsider.com
streetinsider.com - February 26 at 10:25 AM |
| Imara to Present at SVB Leerink 10th Annual Global Healthcare Conference
finance.yahoo.com - February 19 at 7:24 AM |
| Imara Announces the Appointment of Kenneth Attie, M.D. as Chief Medical Officer
finance.yahoo.com - January 20 at 9:18 AM |
| Imara declined yesterday as its sickle cell treatment appears to be not at par with its peers
seekingalpha.com - January 13 at 7:45 AM |
 | Imara Analyst Says Buy The Weakness Ahead Of Multiple 2021 Data Readouts
msn.com - January 6 at 7:24 PM |
| Imara Reports Phase 2a Clinical Trial Results of IMR-687 in Adult Patients with Sickle Cell Disease
finance.yahoo.com - January 6 at 9:11 AM |
| We Think IMARA (NASDAQ:IMRA) Can Afford To Drive Business Growth
finance.yahoo.com - December 10 at 8:31 AM |
| Imara Presents IMR-687 Phase 2a Open Label Extension Case Reports on Two Patients with Sickle Cell Disease at the 62nd ASH Annual Meeting and Exposition
finance.yahoo.com - December 7 at 7:49 AM |
| Do Hedge Funds Love IMARA Inc. (IMRA)?
finance.yahoo.com - December 1 at 12:56 AM |
| Imara to Present Clinical Data on IMR-687 as Monotherapy and in Combination with Hydroxyurea in Patients with Sickle Cell Disease at the 62nd ASH Annual Meeting and Exposition
finance.yahoo.com - November 30 at 2:55 PM |
| Imara Announces the Appointment of Lynette Hopkinson as Senior Vice President of Regulatory
finance.yahoo.com - November 17 at 8:32 AM |
| IMARA Inc.'s (IMRA) CEO Rahul Ballal on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 7 at 11:27 AM |
| Imara Reports Third Quarter 2020 Financial Results and Business Highlights
finance.yahoo.com - November 5 at 9:19 AM |
| Kaskela Law LLC Announces Stockholder Investigation of Imara Inc. - IMRA
finance.yahoo.com - October 31 at 8:43 AM |
| Imara to Webcast Conference Call of Third Quarter Financial Results
finance.yahoo.com - October 29 at 7:23 AM |
| Imara Announces First Patient Dosed in Forte Phase 2b Clinical Trial of IMR-687 in Beta-Thalassemia
finance.yahoo.com - October 16 at 12:54 PM |
| Imara to Present at Upcoming Investor Conferences
finance.yahoo.com - September 2 at 9:31 AM |
| Imara Receives Orphan Drug Designation from the European Commission for IMR-687 for the Treatment of Sickle Cell Disease
finance.yahoo.com - August 25 at 9:37 AM |
| Imara Reports Second Quarter 2020 Financial Results and Business Highlights
finance.yahoo.com - August 14 at 8:08 AM |
